Evaluation of Drug Management Funded by JKN Capitation in Medan Primary Health Centers : Mixed – Methods Study

Authors

  • Nadya Nurul Azrida Nasution Universitas Sumatera Utara
  • Khairunnisa Departemen farmakologi dan farmasi klinis/komunitas, Fakultas farmasi, universitas sumatera utara
  • Dadang Irfan Husori Departemen farmakologi dan farmasi klinis/komunitas, Fakultas farmasi, universitas sumatera utara

DOI:

https://doi.org/10.35451/ynzh5n23

Keywords:

Drug Management, Capitation Fund, National Health Insurance, Primary Healthcare, Mixed-Method

Abstract

Background: Drug management is a critical component of pharmaceutical services in primary healthcare centers, ensuring the availability, quality, and rational use of medicines. Under the National Health Insurance (JKN) system, drug management in primary healthcare centers is largely funded by capitation funds, thus requiring evaluation to assess its compliance with established standards. Aim:  This study aims to evaluate drug management and identify the influencing factors based on JKN capitation funds in primary healthcare centers in Medan City.  Methode: This study employed a mixed-method approach with an explanatory sequential design and was conducted from January to March 2026 in six primary healthcare centers in Medan City. Quantitative data were obtained through direct observation and document review of drug management in 2024, while qualitative data were collected through in-depth interviews with six pharmacists and six heads of healthcare centers. Quantitative data were analyzed descriptively, while qualitative data were analyzed using thematic analysis. Result: The results showed that the planning stage still indicated overplanning and deviations above the standard. The procurement stage did not fully meet the planned targets. However, distribution, and administrative stages were generally in accordance with the standards. Qualitative findings revealed that major constraints included limitations in the e-catalog system, drug availability from suppliers, and limited human resources. Supporting factors included adaptive strategies by pharmacists, stock monitoring systems, and internal policies of healthcare centers Conclusion: The integration of findings indicates that discrepancies in certain indicators are mainly due to systemic factors, particularly in procurement, while the successful stages reflect strong adaptive capacity at the primary healthcare level.

Downloads

Download data is not yet available.

References

[1] Anggriani, Y., dkk. (2020). Evaluasi Perencanaan dan Pengadaan Obat di Era Jaminan Kesehatan Nasional (JKN) di Puskesmas Kabupaten Cianjur. Pharmaceutical Journal of Indonesia. 17 (2): 425-438

[2] Anisah, N., Yunita, S. L., & Hidayati, I. R. (2023). Analisis pengelolaan obat di Puskesmas X Provinsi Kalimantan Selatan. Journal Syifa Sciences and Clinical Research, 5(1), 71–80. https://doi.org/10.37311/jsscr.v5i1.17046

[3] Azizah, N. (2024). Perencanaan pengelolaan obat di fasilitas kesehatan tingkat pertama. Jurnal Manajemen Pelayanan Kesehatan, 25(1), 45–53.

[4] Creswell, J. W., & Plano Clark, V. L. (2018). Designing and Conducting Mixed Methods Research (3rd ed.). Thousand Oaks: SAGE Publications.

[5] Febriawati, H. (2013). Manajemen logistik farmasi rumah sakit. Yogyakarta: Gosyen Publishing.

[6] Indrayani, dkk. (2022). Evaluasi pengelolaan obat di Puskesmas Kabupaten Jombang. Jurnal Kefarmasian.

[7] Menteri Kesehatan Republik Indonesia. (2016). Peraturan Menteri Kesehatan Nomor 74 Tahun 2016 tentang Standar Pelayanan Kefarmasian di Puskesmas. Jakarta: Kemenkes RI.

[8] Menteri Kesehatan Republik Indonesia. (2016). Peraturan Menteri Kesehatan No. 21 Tahun 2016 tentang Penggunaan Dana Kapitasi JKN pada FKTP. Jakarta: Kemenkes RI.

[9] Menteri Kesehatan Republik Indonesia. (2020). Peraturan Menteri Kesehatan Nomor 26 Tahun 2020 tentang Perubahan atas Permenkes Nomor 74 Tahun 2016. Jakarta: Kemenkes RI.

[10] Menteri Kesehatan Republik Indonesia. (2022). Peraturan Menteri Kesehatan Nomor 6 Tahun 2022 tentang Pemanfaatan Dana Kapitasi. Jakarta: Kemenkes RI.

[11] Noviani, L. (2020). Kumpulan standar prosedur dalam pelayanan kefarmasian untuk rumah sakit, Puskesmas, dan apotek. Jakarta: Penerbit Universitas Katolik Indonesia Atma Jaya.

[12] Pemerintah Republik Indonesia. (2009). Peraturan Pemerintah Nomor 51 Tahun 2009 tentang Pekerjaan Kefarmasian. Jakarta: Kementerian Kesehatan Republik Indonesia.

[13] Pujianti, N., Wathan, N., Rahman, F., dkk. (2023). Manajemen logistik medik (Teori & Implementasinya): Indonesia. Banjarmasin: Lambung Mangkurat University Press.

[14] Robbins, S. P., & Judge, T. A. (2018). Perilaku organisasi. Jakarta: Salemba Empat.

[15] Sariah, F., dkk. (2022). Evaluasi pengelolaan obat di Puskesmas Kabupaten X.Jurnal Manajemen Pelayanan Kesehatan, 25(3), 145–153.

[16] Satibi. (2021). Pedoman Evaluasi Pengelolaan Obat Publik dan BMHP di Fasilitas Pelayanan Kesehatan. Yogyakarta: Gadjah Mada University Press.

[17] Satibi, Prasetyo, S. D., Rokhman, M. R., & Aditama, H. (2023). Penilaian mutu pelayanan kefarmasian di Puskesmas. Yogyakarta: UGM Press.

[18] Sugiyono. (2019). Metode Penelitian Kuantitatif, Kualitatif, dan R&D. Bandung: Alfabeta

[19] Soka, B. G., Triani Kurniawati, L. M., & Burhanudin, G. (2025). Manajemen perbekalan dan akuntansi farmasi. Jakarta: Get Press Indonesia.

[20] World Health Organization. (2010). Managing access to medicines and health

[21] NOVYANDINA, Jessyca. Analisis Pengelolaan Dana Kapitasi Jaminan Kesehatan Nasional di

Puskesmas Muara Bungo I Kabupaten Bungo. 2024. PhD Thesis. Universitas Jambi.

[22] SOLAMANDA, ARIZKA AGUS. Analisis Persepsi Pasien Terhadap Sistem Pelayanan Kapitasi Di

Puskesmas Kabupaten Demak Pada Era Jkn. 2022. PhD Thesis. Universitas Islam Sultan Agung

Semarang.

[23] Pudjaningsih, D. (1996). Pengembangan indikator efisiensi pengelolaan obat di farmasi rumah sakit

(Tesis Magister). Universitas Gadjah Mada.

Downloads

Published

2026-10-30

How to Cite

Evaluation of Drug Management Funded by JKN Capitation in Medan Primary Health Centers : Mixed – Methods Study. (2026). JURNAL FARMASIMED (JFM), 9(1), 38-48. https://doi.org/10.35451/ynzh5n23